Recent topics related to etiology and clinical manifestations of cutaneous arteritis
- PMID: 36300176
- PMCID: PMC9589105
- DOI: 10.3389/fmed.2022.1022512
Recent topics related to etiology and clinical manifestations of cutaneous arteritis
Abstract
Cutaneous polyarteritis nodosa (cPAN) was first reported by Lindberg in 1931. It has been recognized as a skin-limited vasculitis whose cutaneous histopathological features are indistinguishable from those of PAN. Cutaneous arteritis (CA) was defined as a form of single-organ vasculitis in the revised Chapel Hill Classification and was recognized as the same disease as cPAN. It became known that deficiency of adenosine deaminase 2 (DADA2) cases were included in cases that had been diagnosed with CA. Because of their similarity and differences in the treatment methods, DADA2 should be considered in CA cases, especially if they are diagnosed or developed in early childhood. Cutaneous arteritis may be classified as an immune complex-mediated vasculitis. It was reported that the pathogenesis of anti-lysosomal-associated membrane protein-2 (LAMP-2) antibodies and anti-phosphatidylserine-prothrombin complex (PS/PT) antibodies as good parameters in CA. The main skin manifestations include livedo racemosa, subcutaneous nodules, and ulcers. Although CA is recognized to have a benign clinical course, it has become known that it is easy to relapse. The existence of skin ulcers upon diagnosis or sensory neuropathies was suggested to be a predictor of poor prognosis. Cutaneous arteritis with them may need to be treated with more intensive therapies.
Keywords: anti-lysosomal-associated membrane protein-2 antibody; anti-phosphatidylserine-prothrombin complex antibody; cutaneous arteritis; deficiency of adenosine deaminase 2; livedo racemosa; polyarteritis nodosa.
Copyright © 2022 Ikeda.
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.Clin Rev Allergy Immunol. 2017 Dec;53(3):452-468. doi: 10.1007/s12016-017-8612-9. Clin Rev Allergy Immunol. 2017. PMID: 28547523 Review.
-
Cutaneous vasculitis in autoinflammatory diseases.J Dermatol. 2024 Feb;51(2):150-159. doi: 10.1111/1346-8138.17030. Epub 2023 Nov 13. J Dermatol. 2024. PMID: 37955334 Review.
-
Correlation of livedo racemosa, cutaneous inflammatory plaques, and antiphospholipid antibodies in patients with cutaneous polyarteritis nodosa.Medicine (Baltimore). 2011 Mar;90(2):119-124. doi: 10.1097/MD.0b013e3182115508. Medicine (Baltimore). 2011. PMID: 21358438
-
Lymphocytic thrombophilic arteritis and cutaneous polyarteritis nodosa: Clinicopathologic comparison with blinded histologic assessment.J Am Acad Dermatol. 2020 Aug;83(2):501-508. doi: 10.1016/j.jaad.2019.10.068. Epub 2020 Feb 7. J Am Acad Dermatol. 2020. PMID: 32044177
-
Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.Rheumatology (Oxford). 2009 May;48(5):508-12. doi: 10.1093/rheumatology/kep036. Epub 2009 Mar 9. Rheumatology (Oxford). 2009. PMID: 19273539
References
-
- Kussmaul A, Maier R. Dtsch Arch Klin Med. (1866) 1:484–518.
-
- Lindberg K. Ein beitrag zur kenntnis der periarteriitis nodosa. Acta Med Scand. (1931) 76:183–225. 10.1111/j.0954-6820.1931.tb18345.x - DOI
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous